Chenyang Wu

577 total citations
15 papers, 439 citations indexed

About

Chenyang Wu is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Chenyang Wu has authored 15 papers receiving a total of 439 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Cancer Research and 3 papers in Oncology. Recurrent topics in Chenyang Wu's work include MicroRNA in disease regulation (4 papers), RNA modifications and cancer (3 papers) and Circular RNAs in diseases (3 papers). Chenyang Wu is often cited by papers focused on MicroRNA in disease regulation (4 papers), RNA modifications and cancer (3 papers) and Circular RNAs in diseases (3 papers). Chenyang Wu collaborates with scholars based in China, Japan and United States. Chenyang Wu's co-authors include Hui Xu, Lin Fang, Bingkun Zhao, Kaiyao Hua, Hongming Song, Jialu Song, Deng‐Feng Li, Niraj Maskey, Junyong Zhao and Jiali Jin and has published in prestigious journals such as Genome Research, Journal of Medicinal Chemistry and Trends in Pharmacological Sciences.

In The Last Decade

Chenyang Wu

14 papers receiving 434 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Chenyang Wu China	13	296	241	77	48	45	15	439
John J. Castorino United States	6	395 1.3×	242 1.0×	66 0.9×	73 1.5×	63 1.4×	8	519
Liang Deng China	12	498 1.7×	332 1.4×	87 1.1×	91 1.9×	33 0.7×	17	623
Matheus Molina Silva Brazil	7	343 1.2×	109 0.5×	151 2.0×	35 0.7×	27 0.6×	8	517
Cécile Thirant France	13	408 1.4×	170 0.7×	141 1.8×	32 0.7×	33 0.7×	18	594
Mary Hahn United States	5	294 1.0×	197 0.8×	202 2.6×	55 1.1×	107 2.4×	7	531
Marta Pojo Portugal	13	350 1.2×	245 1.0×	112 1.5×	24 0.5×	60 1.3×	30	567
Linfang Jin China	13	329 1.1×	227 0.9×	119 1.5×	22 0.5×	29 0.6×	27	538
Ramesh Singh United States	8	715 2.4×	528 2.2×	92 1.2×	27 0.6×	46 1.0×	12	819
Fabio Corrà Italy	10	634 2.1×	505 2.1×	156 2.0×	38 0.8×	30 0.7×	14	828

Countries citing papers authored by Chenyang Wu

Since Specialization

Citations

This map shows the geographic impact of Chenyang Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chenyang Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chenyang Wu more than expected).

Fields of papers citing papers by Chenyang Wu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chenyang Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chenyang Wu. The network helps show where Chenyang Wu may publish in the future.

Co-authorship network of co-authors of Chenyang Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Chenyang Wu. A scholar is included among the top collaborators of Chenyang Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chenyang Wu. Chenyang Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Zhang, Min, et al.. (2025). Cancer driver topologically associated domains identify oncogenic and tumor-suppressive lncRNAs. Genome Research. 35(8). 1842–1858.

Wu, Chenyang, et al.. (2024). The structure and function of olfactory receptors. Trends in Pharmacological Sciences. 45(3). 268–280. 30 indexed citations

Gong, Qijie, Pengfei Wang, Zhan Yu, et al.. (2023). Novel NQO1 substrates bearing two nitrogen redox centers: Design, synthesis, molecular dynamics simulations, and antitumor evaluation. Bioorganic Chemistry. 134. 106480–106480. 2 indexed citations

Wu, Chenyang, et al.. (2023). MIF is a critical regulator of mononuclear phagocytic infiltration in hepatocellular carcinoma. iScience. 26(8). 107273–107273. 12 indexed citations

Wu, Chenyang, Xin Cao, & Xiaojin Zhang. (2021). VISTA inhibitors in cancer immunotherapy: a short perspective on recent progresses. RSC Medicinal Chemistry. 12(10). 1672–1679. 20 indexed citations

Yang, Fulai, Simeng Liu, Chenyang Wu, et al.. (2021). Discovery of a Potent and Orally Bioavailable Hypoxia-Inducible Factor 2α (HIF-2α) Agonist and Its Synergistic Therapy with Prolyl Hydroxylase Inhibitors for the Treatment of Renal Anemia. Journal of Medicinal Chemistry. 64(23). 17384–17402. 15 indexed citations

Liu, Simeng, et al.. (2020). Insight into the binding mode of HIF-2 agonists through molecular dynamic simulations and biological validation. European Journal of Medicinal Chemistry. 211. 112999–112999. 12 indexed citations

Xie, Dan, Hongming Song, Tianqi Wu, et al.. (2018). MicroRNA‑424 serves an anti‑oncogenic role by targeting cyclin‑dependent kinase�1 in breast cancer cells. Oncology Reports. 40(6). 3416–3426. 50 indexed citations

Wu, Tianqi, Hongming Song, Dan Xie, et al.. (2018). Silencing of ASPP2 promotes the proliferation, migration and invasion of triple-negative breast cancer cells via the PI3K/AKT pathway. International Journal of Oncology. 52(6). 2001–2010. 17 indexed citations

10.

Maskey, Niraj, Dengfeng Li, Hui Xu, et al.. (2017). MicroRNA-340 inhibits invasion and metastasis by downregulating ROCK1 in breast cancer cells. Oncology Letters. 14(2). 2261–2267. 39 indexed citations

11.

Xu, Hui, Mingping Qian, Bingkun Zhao, et al.. (2017). Inhibition of RAB1A suppresses epithelial-mesenchymal transition and proliferation of triple-negative breast cancer cells. Oncology Reports. 37(3). 1619–1626. 31 indexed citations

12.

Li, Deng‐Feng, Hong Wang, Hongming Song, et al.. (2017). The microRNAs miR-200b-3p and miR-429-5p target the LIMK1/CFL1 pathway to inhibit growth and motility of breast cancer cells. Oncotarget. 8(49). 85276–85289. 77 indexed citations

13.

Hua, Kaiyao, Jiali Jin, Huiwen Zhang, et al.. (2016). MicroRNA-7 inhibits proliferation, migration and invasion of thyroid papillary cancer cells via targeting CKS2. International Journal of Oncology. 49(4). 1531–1540. 49 indexed citations

14.

Hua, Kaiyao, Jiali Jin, Junyong Zhao, et al.. (2016). miR-135b, upregulated in breast cancer, promotes cell growth and disrupts the cell cycle by regulating LATS2. International Journal of Oncology. 48(5). 1997–2006. 69 indexed citations

15.

Song, Hongming, Chenyang Wu, Chuankui Wei, et al.. (2015). Silencing of DUSP6 gene by RNAi-mediation inhibits proliferation and growth in MDA-MB-231 breast cancer cells: an in vitro study.. PubMed. 8(7). 10481–90. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact